Lacosamide Tablet, Film Coated
Product Images NDC 69367-349

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 69367-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical structure of lacosamide displayed as a skeletal formula showing its molecular arrangement including functional groups such as amide, ether, and aromatic ring components.*

FDA Label Image

Figure 1 (Lacosamide 02)

Bar graph showing seizure reduction as median percent change from baseline across three studies comparing placebo and Lacosamide at various doses (200 mg, 400 mg, 600 mg). The graph indicates higher seizure reduction with Lacosamide doses compared to placebo, with statistical significance noted for Lacosamide groups.*

FDA Label Image

Figure 2 (Lacosamide 03)

A line graph showing the proportion of patients by responder rate (equal to or greater improvement) for Lacosamide and placebo groups across Studies 2, 3, and 4. The x-axis represents the percent of patients decreasing from 100% to 0%, and the y-axis shows responder rate from -100% (worsening) to 100% (improvement). Four lines represent placebo (N=359) and Lacosamide at 200 mg/day (N=267), 400 mg/day (N=466), and 600 mg/day (N=202) doses, illustrating differences in patient response rates.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Label for Lacosamide 50 mg film-coated tablets, USP, from Westminster Pharmaceuticals, LLC. The label includes storage instructions, dispensing guidelines, and indicates a package of 60 tablets. It also features the NDC number 69367-348-60 and states "Rx Only."*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Lacosamide 100 mg film-coated tablets, USP, manufactured for Westminster Pharmaceuticals, LLC. The label includes dosage form, strength, quantity of 60 tablets, storage instructions, and a barcode. It states Rx only and instructs pharmacists to dispense the enclosed medication guide to patients.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Label for Lacosamide Tablets USP 150 mg oral film-coated tablets by Westminster Pharmaceuticals, LLC. The label states the product is prescription only, contains 60 tablets, includes storage instructions between 68° to 77°F, and prescribing information guidance. Manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Lacosamide Tablets, USP 200 mg film-coated oral tablets in a 60-tablet package by Westminster Pharmaceuticals, LLC. The label includes storage instructions, dosage advisory to read prescribing information, and a barcode. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.